Drug
BAY85-3934
BAY85-3934 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
2
40%
Ph phase_1
3
60%
Phase Distribution
3
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
3(60.0%)
Phase 2Efficacy & side effects
2(40.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (60.0%)
Phase 22 (40.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
Single Dose Group Stratified Study in Renal Impaired and Healthy Aged and Gender Matched Subjects
NCT01318551
completedphase_2
15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)
NCT02021370
completedphase_2
Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934
NCT02021409
completedphase_1
Combined Single / Multiple Dose Escalation Study in Patients With Renal Anemia Due to CKD (Chronic Kidney Disease)
NCT01332942
completedphase_1
Age and Gender Effects on the Pharmacokinetics of BAY85-3934
NCT01458028
Clinical Trials (5)
Showing 5 of 5 trials
NCT01318551Phase 1
Single Dose Group Stratified Study in Renal Impaired and Healthy Aged and Gender Matched Subjects
NCT02021370Phase 2
15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)
NCT02021409Phase 2
Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934
NCT01332942Phase 1
Combined Single / Multiple Dose Escalation Study in Patients With Renal Anemia Due to CKD (Chronic Kidney Disease)
NCT01458028Phase 1
Age and Gender Effects on the Pharmacokinetics of BAY85-3934
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5